MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
MicroRNAs (miRNAs) are short non-coding RNAs that play an important role in post-transcriptional regulation of gene expression. The past studies showed that miR-150 might emerge as a master regulator of gene expression during the immune cells differentiation and immune response process. Its regulation ability in immune cellular process might contribute to the host defense against invading pathogens, and dysregulated expression of miR-150 in immune cells might result in autoimmune diseases. This review summarized that miR-150 could regulate B cells, T cells and NK/iNKT cells differentiation and immune response. And also, this review provides a comprehensive view on the association of miR-150 and autoimmune diseases such as systemic sclerosis (SSc), multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus and contact sensitivity. Especially, the duplex role of miR-150 in the fibrosis process might contribute to the pathomechanism of SSc. Though much remains to be explored about the roles of miR-150 in pathogenic infection and autoimmune diseases, targeting miR-150 may serve as a promising therapy strategy.
a Department of Epidemiology and Biostatistics , School of Public Health, Anhui Medical University , Hefei , China and.
Xiao-Lei
XL
Huang
b Medical Genetics Center, Anhui Medical College , Hefei , China.
Li
L
Zhang
b Medical Genetics Center, Anhui Medical College , Hefei , China.
Jian-Ping
JP
Li
a Department of Epidemiology and Biostatistics , School of Public Health, Anhui Medical University , Hefei , China and.
Yu-Jie
YJ
Wang
a Department of Epidemiology and Biostatistics , School of Public Health, Anhui Medical University , Hefei , China and.
Yu
Y
Duan
a Department of Epidemiology and Biostatistics , School of Public Health, Anhui Medical University , Hefei , China and.
Jing
J
Wang
D001172:Arthritis, Rheumatoid / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D001424:Bacterial Infections / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D002454:Cell Differentiation / Q000276:immunology; D003877:Dermatitis, Contact / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D005786:Gene Expression Regulation; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D035683:MicroRNAs / Q000235:genetics / Q000276:immunology*; D012595:Scleroderma, Systemic / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology; D014777:Virus Diseases / Q000235:genetics / Q000276:immunology* / Q000473:pathology
D035683:MicroRNAs; C533097:MIR150, human
Autoimmune diseases; fibrosis; immune cells; microRNA-150; pathogens infection